broad potent hiv neutralization human antibody binds gp41-gp120 interface
isolation human monoclonal antibodies providing important insights specificities underlie broad neutralization hiv reviewed ref report broad extremely potent hiv-specific monoclonal antibody termed 35o22 binds novel hiv envelope glycoprotein env epitope 35o22 neutralized % pseudoviruses half-maximum inhibitory concentration ic50< mu gml- median ic50 neutralized viruses mu gml- among themost potent thus far described 35o22 bind monomeric forms env tested bind trimeric bg505 sosip mutagenesis reconstruction negative-stain electron microscopy fab complex trimer revealed bound conserved epitope stretched across gp120 gp41 specificity 35o22 represents novel site vulnerability hiv env serum analysis indicates commonly elicited natural infection binding new site vulnerability may thus important complement current monoclonal-antibody-based approaches immunotherapies prophylaxis vaccine design
